SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-21-018573
Filing Date
2021-09-14
Accepted
2021-09-14 16:05:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a424b5sept2021prosuppcmpo.htm 424B5 391800
2 GRAPHIC avalotherapeuticslogo.jpg GRAPHIC 7602
3 GRAPHIC cerecorlogoa70.jpg GRAPHIC 16081
4 GRAPHIC pipelinechart_avalo90821.jpg GRAPHIC 115812
  Complete submission text file 0001628280-21-018573.txt   579996
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254000 | Film No.: 211252467
SIC: 2834 Pharmaceutical Preparations